BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery. Diabetes Obes Metab 2014;16:1230-8. [PMID: 25132119 DOI: 10.1111/dom.12376] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A, Onishi S, Kobayashi K, Ogino J, Hashimoto N, Tokuyama H, Shimada F, Ohara E, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Hattori A, Kitamoto T, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Takemoto M, Newby LK, Yokote K; PRIME-V Study Group. Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study). Diabetes Obes Metab 2019;21:1990-5. [PMID: 30993861 DOI: 10.1111/dom.13750] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
2 Malin SK, Liu Z, Barrett EJ, Weltman A. Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolism. Rev Endocr Metab Disord 2016;17:81-90. [PMID: 27106830 DOI: 10.1007/s11154-016-9352-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
3 Baltieri L, Chaim EA, Chaim FDM, Utrini MP, Gestic MA, Cazzo E. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS. Arq Gastroenterol 2018;55:247-51. [DOI: 10.1590/s0004-2803.201800000-62] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
4 Malkani S. An update on the role of bariatric surgery in diabetes management. Current Opinion in Endocrinology, Diabetes & Obesity 2015;22:98-105. [DOI: 10.1097/med.0000000000000143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
5 Carbone F, Adami G, Liberale L, Bonaventura A, Bertolotto M, Andraghetti G, Scopinaro N, Camerini GB, Papadia FS, Cordera R, Dallegri F, Montecucco F. Serum levels of osteopontin predict diabetes remission after bariatric surgery. Diabetes Metab. 2019;45:356-362. [PMID: 30268840 DOI: 10.1016/j.diabet.2018.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
6 O'Rourke RW, Johnson GS, Purnell JQ, Courcoulas AP, Dakin GF, Garcia L, Hinojosa M, Mitchell JE, Pomp A, Pories WJ, Spaniolas K, Flum DR, Wahed AS, Wolfe BM. Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes. Int J Obes (Lond) 2019;43:285-96. [PMID: 29777230 DOI: 10.1038/s41366-018-0088-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
7 Malin SK, Kaplan JL, Meng L, Garmey JC, Kirby JL, Taylor AM, Hallowell PT, McNamara CA. Age increases MCP-1 level in association with bariatric surgery operating time and metabolic risk severity. Obes Sci Pract 2017;3:193-200. [PMID: 28706732 DOI: 10.1002/osp4.105] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Gómez-martin JM, Balsa JA, Aracil E, Insenser M, Priego P, Escobar-morreale HF, Botella-carretero JI. Circulating adiponectin increases in obese women after sleeve gastrectomy or gastric bypass driving beneficial metabolic changes but with no relationship with carotid intima-media thickness. Clinical Nutrition 2018;37:2102-6. [DOI: 10.1016/j.clnu.2017.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
9 Hankir MK, Bronisch F, Hintschich C, Krügel U, Seyfried F, Fenske WK. Differential effects of Roux-en-Y gastric bypass surgery on brown and beige adipose tissue thermogenesis. Metabolism 2015;64:1240-9. [PMID: 26211711 DOI: 10.1016/j.metabol.2015.06.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
10 Iqbal Z, Adam S, Ho JH, Syed AA, Ammori BJ, Malik RA, Soran H. Metabolic and cardiovascular outcomes of bariatric surgery. Curr Opin Lipidol 2020;31:246-56. [PMID: 32618731 DOI: 10.1097/MOL.0000000000000696] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Menguer RK, Weston AC, Schmid H. Evaluation of Metabolic Syndrome in morbidly Obese Patients Submitted to Laparoscopic Bariatric Surgery: Comparison of the Results between Roux-En-Y Gastric Bypass and Sleeve Gastrectomy. Obes Surg 2017;27:1719-23. [PMID: 28176218 DOI: 10.1007/s11695-017-2547-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
12 Lu C, Li Z, Yang J, Feng L, Wang C, Shi Q. Variations in Irisin, Bone Mineral Density, Bone Mineral Content, and Body Composition After Laparoscopic Bariatric Procedures in Obese Adults. J Clin Densitom 2020;23:244-53. [PMID: 31133501 DOI: 10.1016/j.jocd.2019.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 O’leary VB, Kirwan JP. Adiponectin, Obesity, and Cancer. In: Reizes O, Berger NA, editors. Adipocytokines, Energy Balance, and Cancer. Cham: Springer International Publishing; 2017. pp. 21-38. [DOI: 10.1007/978-3-319-41677-9_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Malin SK, Kashyap SR. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes. Surgery for Obesity and Related Diseases 2016;12:1213-9. [DOI: 10.1016/j.soard.2016.02.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
15 Malin SK, Kashyap SR. Type 2 Diabetes Treatment in the Patient with Obesity. Endocrinol Metab Clin North Am 2016;45:553-64. [PMID: 27519130 DOI: 10.1016/j.ecl.2016.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
16 Bonaventura A, Liberale L, Carbone F, Scopinaro N, Camerini G, Papadia F, Cordera R, Dallegri F, Adami G, Montecucco F. High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion. Nutrition, Metabolism and Cardiovascular Diseases 2017;27:423-9. [DOI: 10.1016/j.numecd.2017.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
17 Mehaffey JH, Mullen MG, Mehaffey RL, Turrentine FE, Malin SK, Kirby JL, Schirmer B, Hallowell PT. Type 2 diabetes remission following gastric bypass: does diarem stand the test of time? Surg Endosc 2017;31:538-42. [PMID: 27177952 DOI: 10.1007/s00464-016-4964-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
18 Urbanavicius V, Juodeikis Z, Dzenkeviciute V, Galkine A, Petrulioniene Z, Sapoka V, Brimiene V, Vitkus D, Brimas G. A prospective 4-year study of insulin resistance and adipokines in morbidly obese diabetic and non-diabetic patients after gastric banding. Wideochir Inne Tech Maloinwazyjne 2017;12:147-53. [PMID: 28694900 DOI: 10.5114/wiitm.2017.67207] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Neff KJ, O'Donohoe PK, le Roux CW. Anti-inflammatory effects of gastric bypass surgery and their association with improvement in metabolic profile. Expert Rev Endocrinol Metab 2015;10:435-46. [PMID: 30293493 DOI: 10.1586/17446651.2015.1054808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Martin WP, Docherty NG, Le Roux CW. Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms. Expert Rev Endocrinol Metab 2018;13:251-62. [PMID: 30231777 DOI: 10.1080/17446651.2018.1518130] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
21 Faramia J, Ostinelli G, Drolet-Labelle V, Picard F, Tchernof A. Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines. Curr Opin Pharmacol 2020;52:67-74. [PMID: 32688292 DOI: 10.1016/j.coph.2020.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
22 Zhou M, Wang L, Zhou L, Chang X, Zhu X. Novel Insight into the Mechanism of Metabolic Surgery Causing the Diversity in Glycemic Status in Type 2 Diabetes. Exp Clin Endocrinol Diabetes 2022. [PMID: 34979572 DOI: 10.1055/a-1708-3214] [Reference Citation Analysis]
23 Rafey MF, Abdalgwad R, O'shea PM, Foy S, Claffey B, Davenport C, O'keeffe DT, Finucane FM. Changes in the Leptin to Adiponectin Ratio Are Proportional to Weight Loss After Meal Replacement in Adults With Severe Obesity. Front Nutr 2022;9:845574. [DOI: 10.3389/fnut.2022.845574] [Reference Citation Analysis]
24 Gilbertson NM, Paisley AS, Kranz S, Weltman A, Kirby JL, Hallowell PT, Malin SK. Bariatric Surgery Resistance: Using Preoperative Lifestyle Medicine and/or Pharmacology for Metabolic Responsiveness. Obes Surg 2017;27:3281-91. [PMID: 29058238 DOI: 10.1007/s11695-017-2966-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
25 Pérez-Pevida B, Escalada J, Miras AD, Frühbeck G. Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery. Front Endocrinol (Lausanne) 2019;10:641. [PMID: 31608010 DOI: 10.3389/fendo.2019.00641] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
26 Shimizu H, Hatao F, Imamura K, Takanishi K, Tsujino M. Early Effects of Sleeve Gastrectomy on Obesity-Related Cytokines and Bile Acid Metabolism in Morbidly Obese Japanese Patients. Obes Surg 2017;27:3223-9. [PMID: 28569359 DOI: 10.1007/s11695-017-2756-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
27 Yan W, Bai R, Yan M, Song M. Preoperative Fasting Plasma C-Peptide Levels as Predictors of Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: A Systematic Review and Meta-Analysis. Journal of Investigative Surgery 2016;30:383-93. [DOI: 10.1080/08941939.2016.1259375] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
28 Mocanu V, Nasralla A, Dang J, Jacobson M, Switzer N, Madsen K, Birch DW, Karmali S. Ongoing Inconsistencies in Weight Loss Reporting Following Bariatric Surgery: a Systematic Review. Obes Surg 2019;29:1375-87. [PMID: 30671713 DOI: 10.1007/s11695-018-03702-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Terenzi DC, Trac JZ, Teoh H, Gerstein HC, Bhatt DL, Al-Omran M, Verma S, Hess DA. Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk. Trends Mol Med 2019;25:640-55. [PMID: 31053416 DOI: 10.1016/j.molmed.2019.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
30 Engin A. Does Bariatric Surgery Improve Obesity Associated Comorbid Conditions. Adv Exp Med Biol 2017;960:545-70. [PMID: 28585216 DOI: 10.1007/978-3-319-48382-5_24] [Reference Citation Analysis]
31 Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Metabolic and Endocrine Consequences of Bariatric Surgery. Front Endocrinol (Lausanne) 2019;10:626. [PMID: 31608009 DOI: 10.3389/fendo.2019.00626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
32 Kheniser KG, Aminian A, Kashyap SR. A Review of the Current Evidence: Impact of Metabolic Surgery on Diabetes Outcomes and Obesity-Associated Macrovascular Complications. Curr Diab Rep 2020;20:57. [PMID: 32984918 DOI: 10.1007/s11892-020-01350-8] [Reference Citation Analysis]
33 Malin SK, Kashyap SR. Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery. Curr Obes Rep 2015;4:279-86. [DOI: 10.1007/s13679-015-0151-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
34 Khanna V, Kashyap SR. Clinical Management of Type 2 Diabetes Mellitus after Bariatric Surgery. Curr Atheroscler Rep 2015;17:59. [PMID: 26303454 DOI: 10.1007/s11883-015-0537-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Stewart J, Allen S, Weidman-Evans E. Bariatric surgery and type 2 diabetes. JAAPA 2020;33:28-32. [PMID: 31880647 DOI: 10.1097/01.JAA.0000615484.77430.1b] [Reference Citation Analysis]